|
Volumn 8, Issue 1, 2005, Pages 67-76
|
M-40403 Metaphore Pharmaceuticals
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOKINE;
DNA;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INTERLEUKIN 2;
MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE);
MORPHINE;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
OPIATE;
OXYGEN RADICAL;
PLACEBO;
SUPEROXIDE;
SUPEROXIDE DISMUTASE;
ANALGESIA;
ANTIINFLAMMATORY ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
ATOPIC DERMATITIS;
BLOOD PRESSURE REGULATION;
CANCER CHEMOTHERAPY;
CANCER PAIN;
CANCER RADIOTHERAPY;
CELL PROTECTION;
CLINICAL TRIAL;
CYTOKINE RELEASE;
DIABETES MELLITUS;
DIABETIC ANGIOPATHY;
DIABETIC NEUROPATHY;
DISEASE ASSOCIATION;
DNA DAMAGE;
DRUG ABUSE;
DRUG BLOOD LEVEL;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG SAFETY;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
HUMAN;
INFLAMMATION;
KIDNEY CARCINOMA;
MOUSE;
NEUROPATHIC PAIN;
NONHUMAN;
PATENT;
POSTOPERATIVE PAIN;
PSORIASIS;
RAT;
REPERFUSION INJURY;
SIDE EFFECT;
SKIN CANCER;
SKIN DISEASE;
STRUCTURE ACTIVITY RELATION;
TOOTH PAIN;
ANALGESICS;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
DRUGS, INVESTIGATIONAL;
FREE RADICAL SCAVENGERS;
HUMANS;
ORGANOMETALLIC COMPOUNDS;
TECHNOLOGY, PHARMACEUTICAL;
|
EID: 13444250068
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|